Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA

Abstract Background We evaluated quality of life among subjects with upper- and lower-limb spasticity who received escalating doses of incobotulinumtoxinA (total body doses up to 800 U) in the prospective, single-arm, dose-titration TOWER study. Methods In this exploratory trial, subjects (N = 155;...

Full description

Bibliographic Details
Main Authors: Klemens Fheodoroff, Tiina Rekand, Luisa Medeiros, Peter Koßmehl, Jörg Wissel, Djamel Bensmail, Astrid Scheschonka, Birgit Flatau-Baqué, Olivier Simon, Dirk Dressler, David M. Simpson
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Health and Quality of Life Outcomes
Subjects:
Botulinum neurotoxin
IncobotulinumtoxinA
Long-term care
Lower limb
Quality of life
Spasticity
Online Access:http://link.springer.com/article/10.1186/s12955-020-01304-4

Internet

http://link.springer.com/article/10.1186/s12955-020-01304-4

Similar Items